MARAVAI LIFESCIENCES HOLDINGS, INC. - Class A Common Stock, par value $0.01 per share (MRVI)

Historical Holders from Q4 2020 to Q3 2025

Symbol
MRVI on Nasdaq
CUSIP
56600D107
Type / Class
Equity / Class A Common Stock, par value $0.01 per share
Shares outstanding
145M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
131M
Holdings value
$375M
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
156
Number of buys
73
Number of sells
-62
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of MARAVAI LIFESCIENCES HOLDINGS, INC. - Class A Common Stock, par value $0.01 per share (MRVI)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
12 West Capital Management LP 8.2% $24M 11.6M 12 West Capital Management LP Dec 31, 2024
FELDMAN STUART 6.17% +28% $25.7M $5.96M 8.94M +30.2% Stuart Feldman Sep 30, 2025
BlackRock, Inc. 5.9% $24.6M 8.58M BlackRock, Inc. Sep 30, 2025
VANGUARD GROUP INC 4.92% -22.7% $20.5M -$6.47M 7.13M -24% The Vanguard Group Sep 30, 2025

Institutional Holders of MARAVAI LIFESCIENCES HOLDINGS, INC. - Class A Common Stock, par value $0.01 per share (MRVI)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 131M $375M +$4.44M $2.87 156
2025 Q2 130M $312M +$3.79M $2.41 147
2025 Q1 129M $284M -$79.9M $2.21 183
2024 Q4 140M $761M -$45.9M $5.45 180
2024 Q3 144M $1.2B -$27.8M $8.31 216
2024 Q2 147M $1.05B +$78.1M $7.16 198
2024 Q1 135M $1.17B +$20.2M $8.67 205
2023 Q4 135M $883M -$24.1M $6.55 218
2023 Q3 135M $1.34B +$65.5M $10.00 199
2023 Q2 127M $1.58B -$25.4M $12.43 216
2023 Q1 128M $1.79B +$16.9M $14.01 208
2022 Q4 127M $1.81B -$140M $14.31 201
2022 Q3 131M $3.33B -$31.4M $25.53 185
2022 Q2 131M $3.72B +$80.2M $28.41 200
2022 Q1 128M $4.51B -$19.2M $35.27 227
2021 Q4 128M $5.36B -$44.1M $41.90 218
2021 Q3 128M $6.27B +$685M $49.08 222
2021 Q2 114M $4.77B +$738M $41.73 192
2021 Q1 98.4M $3.51B +$131M $35.64 139
2020 Q4 97.4M $2.73B +$1.94B $28.05 113